The threat of infectious diseases continues to evolve and major pharmaceutical companies are scaling back research into new medicines to fight against drug-resistant infections.

Could we be one of the Last? Discover why we're Upping the Anti - read more here 

  

NP-EU-NP-0394 Nov 2026